119. Using nephropathy as an outcome to determine the HbA1c diagnostic threshold for type 2 diabetes
Alexandra E. Butler a,*, Steven C. Hunt b,c,1, Eric S. Kilpatrick
Alexandra E. Butler a,*, Steven C. Hunt b,c,1, Eric S. Kilpatrick
Mahboubeh R. Rostami, Philip L. Leopold, Jenifer M. Vasquez, Miguel de Mulder Rougvie, Alya Al Shakaki, Ali Ait Hssain, Amal Robay, Neil R. Hackett, Jason G. Mezey, Ronald G. Crystal
Zeyaul IslamID , Abdoulaye Diane, Namat Khattab, Mohammed Dehbi, Paul Thornalley, Prasanna R. Kolatkar
Mohammad Tariqul Islam; Hesham Zaky; Tanvir Alam
Hamada R. H. Al-Absi, Anant Pai, Usman Naeem, Fatma Kassem Mohamed, Saket Arya, Rami Abu Sbeit, Mohammed Bashir, Maha Mohammed El Shafei, Nady El Hajj & Tanvir Alam
Fatima Qafoud. Khalid Kunji,Mohamed Elshrif, Asma Althani, Amar Salam, Jassim Al Suwaidi, Dawood Darbar, Nidal Asaad , Mohamad Saad
GauravThareja, AzizBelkadi, MatthiasArnold, OmarM.E.Albagha5, JohannesGraumann, FrankSchmidt, HaraldGrallert, AnnettePeters, ChristianGieger, KarstenSuhre
Hanaa Mousa , Aisha Al saei , Rozaimi Mohamad Razali, Susu M. Zughaier
Hanaa Mousa , Mohamed A. Elrayess , Ilhame Diboun, Simon K. Jackson and Susu M. Zughaier
Hanaa Mousa, Nazmul Islam , Vijay Ganji and Susu M. Zughaier